Net Income

With its CFO departing after a major strategic pivot, AAR CORP. names a 13-year insider as his interim replacement. What does this signal for investors?

Promising Phase 3 data reveals a novel, organ-sparing laser therapy for a rare cancer, signaling a potential paradigm shift away from radical surgery.

A class action lawsuit against Telix Pharmaceuticals reveals the perilous gap between optimistic corporate disclosures and harsh regulatory setbacks.

While official data points to growth, new metrics reveal nearly 25% of workers are functionally unemployed, exposing a deep affordability crisis.

A promising fintech's complex arbitrage strategy collapses, triggering a stock crash, CEO exit, and a wave of securities fraud investigations.

MicroCloud Hologram is betting $400M on a quantum-driven 3D model. Is it a revolutionary leap for digital creation or a costly gamble on unproven tech?

A last-minute regulatory filing by Balyasny Asset Management pulls back the curtain on the multi-billion-dollar battle for Spectris, a key health tech enabler.

How Winemaker of the Year Jesse Katz blends record-setting sales, historic vineyards, and philanthropy to disrupt the ultra-premium wine market.

A regulatory filing shows hedge fund Balyasny's active trading in Avadel Pharma, exposing a merger arbitrage strategy amid a fierce bidding war.

The battery innovator secures fresh capital to scale its 'One-Pot' process. We analyze if this move signals a turning point for investors and the EV market.

Praxie has launched a no-code AI platform empowering managers to build their own solutions, tackling the complexity and cost that plague enterprise AI.

From AI-powered planning to exclusive lounges and hidden gem destinations, discover the trends reshaping how we'll travel and spend in 2026.

A major CRO presents 10 pivotal studies at the world's top blood disease meeting, revealing a strategy built on real-world data and collaborative innovation.

SkinSpirit's new Princeton clinic isn't just an expansion; it's a strategic move in the booming medical aesthetics market. Here's why it matters.